Radiometer logo

Cord blood sampling

A method for determining birth asphyxia at the moment of delivery

The pH, pCO2 and base excess from the cord arteries provide valuable objective evidence of the metabolic condition of neonates at the moment of delivery, which makes the use of blood gas analysis relevant for the Neonatal Intensive Care Units.

According to the World Health organization there has been a substantial decline, none the less it is estimated that most neonatal death (75%) occur during the first week of life, and in 2019 about 1 million newborns died within the first 24 hours.

Preterm birth, childbirth-related complications (birth asphyxia or lack of breathing at birth), infections and birth defects cuased most neonatel deaths in 2019.

Cord blood analysis is an objective measure of the fetal metabolic condition at the time of delivery. By determining fetal acid-base status, it helps identify infants at risk for neonatal encephalopathy.

Contact us
Get in touch to hear more about cord blood sampling and our NICU solutions

Contact Info

Workplace Details

By submitting this form, I acknowledge that I have reviewed and understood the data privacy notice.

All fields must be filled!

  • What is the clinical relevance of the determination of the acid-base values of the cord blood of the newborn, and what are acceptable values? 
  • How and when should the sample be collected?
  • Why should you collect a blood sample from both a cord artery and the cord vein?
  • Which parameters are important to measure: pH, pCO2, base excess, lactate...?
  • Should cord blood gas analysis be reserved for selected neonates or should it be applied for all neonates?
  • What is the value of cord blood gas on record for all neonates in case of litigation?
  • What do your national guidelines indicate and how do they compare to guidelines around the world?
     

Get the answers in Chris Higgins’ article ‘Umbilical-cord blood gas analysis’ published on acutecaretesting.org.

Supporting neonatal care

Immediately after birth, cord blood gas testing is performed to determine the acid-base status of the neonate at the moment of delivery in order to detect birth asphyxia. The cord blood gas result can also be used to document quality of care [1] and can prove to be important documentation in case of litigation [2].

Radiometer’s ABL90 FLEX PLUS blood gas analyser and safePICO arterial blood gas syringes, provides fast and accurate results on critical parameters for the assessment of the neonate.

Proven measuring performance means reliable results

Accurate test results on cord blood samples are critical for making well-informed medical assessments of the neonate’s wellbeing.

The integrated sample mixer on the ABL90 FLEX PLUS analyser enables fast and standardised mixing of safePICO arterial blood gas syringes. That helps obtain a homogeneous and reduce the risk for clots.

Nurse performing a blood gas analysis on the ABL90 FLEX plus from RadiometerNurse performing a blood gas analysis on the ABL90 FLEX plus from Radiometer

References

  1. Perinatal Safety Programme – a quality project in all maternity wards in Denmark] Sikre fødsler – et kvalitetsprojekt på alle fødeafdelinger I Danmark. http://www.regioner.dk/sundhed/kvalitet/patientsikkerhed/sikre+fødsler. Accessed 2014-10-10
  2. Boog, G. [Cerebral palsy and perinatal asphyxia (II--Medicolegal implications and prevention)] Asphyxie périnatale et infirmité motrice d'origine cérébrale (II - Implications médico-légales et prévention). Gynecol Obstet Fertil 2011; 39(3): 146-73.

MAPSSS-000423 R2

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

Sorry

It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
  •    
  • Single-sign on experience
  •    
  • Use same credentials to access future services    

Request access

You will receive an invitation to access our services via e-mail when your request  has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.